Navigation Links
Genetic link uncovered in disparate colon cancer death
Date:3/31/2009

BIRMINGHAM, Ala. A new study reveals the first-ever genetic link to the reason African-Americans are at increased risk of dying from colon cancer.

The discovery by researchers at the University of Alabama at Birmingham (UAB) is focused on a protein variant called Pro72 identified through genetic testing. In the study, African-Americans with a Pro72 protein variant had more than double the risk of dying from an advanced form of colon cancer compared to whites, the researchers said.

The discovery boosts the scientific understanding of racial disparities in cancer and other diseases and adds new detail in the ongoing search for more personalized cancer-fighting therapies, said Upender Manne, Ph.D., an associate professor in the UAB Department of Pathology who led the study.

The findings are published in the April 1 issue of the journal Clinical Cancer Research.

Pro72 is a molecule that arises from alterations in a tumor suppressor gene called p53, a gene that has been linked to half of all cancers in the world.

"This paper shows that in a subset of patients with the Pro72 variant, the susceptibility to disruptive p53 alterations may be a possible molecular explanation for the racial disparity," said Manne, an associate scientist in the UAB Comprehensive Cancer Center.

The study included DNA analysis of 373 colorectal tumors. Researchers first sequenced the whole p53 gene in the tumors, and then analyzed the Pro72 frequency. Seventeen percent of African-Americans have a Pro72 variant, whereas only 7 percent of whites have the variant, Manne said.


'/>"/>

Contact: Troy Goodman
tdgoodman@uab.edu
205-934-8938
University of Alabama at Birmingham
Source:Eurekalert

Page: 1

Related medicine news :

1. Many Parents Share Genetic Test Findings With Kids
2. Genetic predisposition increases childhood asthma risk
3. New Alzheimers findings: High stress and genetic risk factor lead to increased memory decline
4. Test Spots Genetic Damage Done by Smoking
5. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
6. Scientists highlight benefits of genetic research in sport, but warn of ethical concerns
7. Genetics Hold Promise, Challenges for Cancer Care
8. Researchers genetically engineer micro-organisms into tiny factories
9. Study Questions Genetic Screening for Treatable Diseases
10. Researchers provide genetic associations from a genome-wide scan for cardiovascular disease traits
11. Genetic variation affects smoking cessation treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... , ... Providing broad access to life-saving drugs and rewarding the innovators who ... to address this problem. , That was the message from Dana Goldman, PhD, Leonard ... University of Southern California, who served as the keynote speaker for Western University of ...
(Date:4/21/2017)... ... April 21, 2017 , ... Evoke ... young adults, has kicked off its 4th annual Forum for Innovative Treatment Solutions ... is “Attachment Informed Therapy for Mental Health and Addiction.” , FITS’ 2017 ...
(Date:4/21/2017)... ... April 21, 2017 , ... The adage “Show, don’t ... the next project in the company’s esteemed VISION House demonstration project series. Manifesting the ... the amount of resources they need to live affordably and abundantly without unduly taxing ...
(Date:4/21/2017)... ... April 21, 2017 , ... Crossover Symmetry , ... , an active lifestyle company that provides Human Performance Training and education to ... offers, first responders, military officers and others in service through the development and ...
(Date:4/21/2017)... ... April 21, 2017 , ... Northern California Medical ... Care Spring Symposium on April 1, 2017 in Santa Rosa. This well-attended annual ... healthcare providers an opportunity to learn about cutting edge treatments, to collaborate, share ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), ... Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Executive Officer of the Company is scheduled to present on Tuesday, ... and the Chairman of the Board, Tony Holler ... ...
(Date:4/19/2017)... 2017 Global Surgical Drainage Device Market: Overview ... to remove excess liquid and air. The fluid to ... or lymph. Surgical drains are used in a wide ... surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. Common use ... accumulation of fluid e.g. blood or pus. Surgical drains ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
Breaking Medicine Technology: